Multicentric phase II trial: evaluation of efficacy and safety of FOLFIRI association treatment in patients 70 years old and more presenting gastric cancer locally advanced or metastatic.
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2011
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms CEPAFIRI
- 28 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.